Navigation Links
Did Medicare Reimbursement Changes Affect Prostate Cancer Treatment?
Date:4/7/2008

Study suggests a link between less drug therapy and more surgical castration

MONDAY, April 7 (HealthDay News) -- In 2004, Medicare reduced its reimbursement rates to doctors for drugs that treat prostate cancer by blocking the activity of male hormones.

Coincidentally or not, the use of surgery -- castration -- to accomplish that same goal started to increase at just the same time, a new study found.

It's not possible to say that financial incentives had a direct influence on medical practice in the treatment of prostate cancer, said Dr. J. Stephen Jones, chairman of regional urology at the Cleveland Clinic, who led the study. "Certainly, I would not take that interpretation," he said, citing other possible explanations, such as increased concern about the side effects of the hormone-blocking drugs.

Still, Jones added, after the reimbursement rates were cut, "our study shows, essentially aligned with that change, progressive change in the two forms of treatment for prostate cancer. There was a major reduction in the use of lutenizing hormone-releasing (LHRH) agonists, which block the male hormone testosterone, and a less noticeable increase in surgery, which accomplishes the same thing," he said.

The use of only one of the LHRH agonists -- triptorelin -- increased after the Medicare reimbursement policy changed, the study said. It was the only drug in the class whose reimbursement rate was not changed.

The findings were expected to be published in the May 15 issue of the journal Cancer.

Medically, the drug therapy -- sometimes called hormonal castration -- and surgery are virtually equivalent in their effect on prostate cancer, Jones said. The goal is to combat the disease by shutting off the supply of male hormones -- called androgens, including testosterone -- that encourage prostate cancer growth.

But "socially or economically, there are other factors involved," Jon
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Medicare Bidding Program in Kansas City is Plagued by Problems, Says American Association for Homecare
2. Errors Plague Medicare Competitive Bidding Program in Ohio, Says American Association for Homecare
3. The Quantum Group Announces Increased Patient Enrollment Following Medicare Advantage Open Enrollment Period
4. Owner of Medicare Billing Service Sentenced to 10 Years In Prison For Role in $170 Million Medicare Fraud Scheme
5. Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters
6. CMS Releases Final E-Prescribing Standards in Medicare
7. Seven Miami-Area Residents Charged in $11 Million Medicare Fraud Scheme
8. Front Line Caregivers from 16 States to Visit Capitol Hill to Urge State Congressional Delegation to Reject Medicare Cuts that Could Threaten Quality Care in Nations Nursing Homes
9. Medicare Advantage Plans Have New, Better Way to Access CMS Data
10. Two Florida Men Sentenced To Prison For Medicare Fraud
11. National, State Front Line Caregivers Warn About $64 Million Cut to Medicare Funding for Care of Michigan Seniors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many trendy ... on Facebook, Twitter, and Pinterest. The fans will have an ... lottery every week. , Moreover, the company has extended its ... Angelweddingdress homepage for more information. , Angelweddingdress is ...
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 A ... issue of experience and person-centeredness in the long-term care ... towards action across the continuum. The paper, “The Power ... Continuum,” engages perspectives and practices of the patient, resident ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
(Date:1/22/2015)... Four years since the release of their debut recording Love ... of Avasa & Matthew Love – the duo are pleased to ... through White Swan Records on February 24, 2015. , THE ROAD ... available to all of us to walk out of the mire ...
(Date:1/22/2015)... 22, 2015 Compare-autoinsurance.org has released a new blog ... an auto insurance policy . , Some types of ... should check the newly released blog post to see if their ... dangerously damaged vehicles are some of the cars that cannot be ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... Global,s shared e-clinical service desk expands support to another ... leading ... Inc. (Nasdaq: TEAM ), a worldwide provider of information ... its subsidiary, TechTeam Global nv/sa, has been selected by,sanofi-aventis recherche ...
... MA--Researchers from Boston University School of Medicine have developed ... cancer. The model combines a specific gene expression ... These findings currently appear on-line in the journal ... leading cause of cancer death in the United States ...
... CHAPEL HILL, N.C., April 1, 2008 Faced ... forces are,having a challenging time serving the hospital ... to shrink, sales reps for the,pharma industry are ... win a place on formularies, according to research ...
... with Guaranteed Withdrawal Benefit, Turns Assets from Retirement ... ... Fortune 1000 Employees, NEW YORK, April 1, 2008 ... variable annuities,today launched a new variable annuity -- Crossings(SM): My ...
... Many top-selling drugs used to treat cancer and ... which are found in nature but historically difficult for ... For the first time, scientists at UC Irvine have ... easier for chemists to manipulate them into new drugs. ...
... 2008) Many patients who come to the ... are already taking 75mg of clopidogrel daily to ... 600-mg reloading dose of clopidogrel significantly improves clinical ... in patients with acute coronary syndromes (ACS), according ...
Cached Medicine News:Health News:TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement 2Health News:TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement 3Health News:Researchers develop new method to test for lung cancer 2Health News:Effectively Influencing the Hospital Marketplace to Win a Place on Formularies 2Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 2Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 3Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 4Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 5Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 6Health News:AXA Equitable Unveils Crossings(SM): My Lifetime IRA(SM) 7Health News:Scientists solve mystery of polyketide drug formation 2Health News:Clopidogrel reloading worthwhile in acute coronary syndromes 2
(Date:1/23/2015)... N.J. , Jan. 23, 2015  CytoSorbents Corporation ... commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce ... announced the receipt of $385,642, net of transaction ... of the Technology Business Tax Certificate Transfer Program ...
(Date:1/23/2015)... , Jan. 23, 2015 Tianyin Pharmaceutical Inc. (NYSE ... specializes in the development and sale of patented biopharmaceutical ... active pharmaceutical ingredients (API) today announced the business and ... operation. 1. Following the September 2014 JCM ...
(Date:1/22/2015)... Jan. 22, 2015  ResMed Inc. (NYSE: RMD ) ... Revenue for the quarter was $423.0 million, a 10 percent ... 14 percent increase on a constant currency basis). Net income ... the quarter ended December 31, 2013. Diluted earnings per share ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... 21, 2011  BARRX Medical Inc., a leader in developing ... to remove precancerous tissue from the gastrointestinal tract, announces ... be acquired by Covidien.  Covidien is a leading global ... advanced energy-based devices.  Covidien will acquire ...
... NORRITON, Pa., Nov. 21, 2011 Tengion, Inc. (NASDAQ: ... today announced that Brian Davis, Vice President Finance and ... upcoming Piper Jaffray 23rd Annual Health Care Conference on ... A live audio webcast of the presentation ...
Cached Medicine Technology:BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien 2BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien 3Tengion to Present at Piper Jaffray 23rd Annual Health Care Conference 2
For the quantitative determination of uric acid in serum....
The assay kit is for determination of uric acid in serum or urine. Wavelength: 600 nm. Linear range: up to 80 mg/dL....
For the quantitative determination of Uric Acid in serum. Linearity: 25 mg/dl....
... A fully automated, random ... over 50 assays available ... tumor marker, therapeutic drug, ... testing can be performed ...
Medicine Products: